Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.55
+0.45 (4.95%)
At close: Mar 6, 2026, 4:00 PM EST
9.52
-0.03 (-0.31%)
After-hours: Mar 6, 2026, 7:50 PM EST
Vir Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 65.17 | 71.86 | 84.07 | 1,616 | 1,095 | Upgrade
|
| Other Revenue | 3.39 | 2.34 | 2.11 | - | - | Upgrade
|
| Revenue | 68.56 | 74.21 | 86.18 | 1,616 | 1,095 | Upgrade
|
| Revenue Growth (YoY) | -7.61% | -13.89% | -94.67% | 47.50% | 1334.39% | Upgrade
|
| Cost of Revenue | 444.5 | 492.79 | 572.83 | 620.97 | 513.87 | Upgrade
|
| Gross Profit | -375.95 | -418.59 | -486.65 | 994.83 | 581.54 | Upgrade
|
| Selling, General & Admin | 92.07 | 119.03 | 174.44 | 161.76 | 160.79 | Upgrade
|
| Operating Expenses | 92.07 | 119.03 | 174.44 | 161.76 | 160.79 | Upgrade
|
| Operating Income | -468.02 | -537.62 | -661.09 | 833.07 | 420.75 | Upgrade
|
| Interest & Investment Income | 40.24 | 71.81 | 86.99 | 28.09 | 0.44 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.41 | -2.22 | -8.99 | 4.26 | -9.44 | Upgrade
|
| EBT Excluding Unusual Items | -428.19 | -468.03 | -583.09 | 865.42 | 411.75 | Upgrade
|
| Merger & Restructuring Charges | 0.18 | -35 | -13.56 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.73 | -5.53 | -21.89 | -111.14 | 138.05 | Upgrade
|
| Asset Writedown | - | -14.55 | -9.66 | - | - | Upgrade
|
| Other Unusual Items | -11.49 | - | - | - | - | Upgrade
|
| Pretax Income | -437.77 | -523.11 | -628.19 | 754.28 | 549.8 | Upgrade
|
| Income Tax Expense | 0.22 | -1.15 | -13.08 | 238.44 | 21.22 | Upgrade
|
| Earnings From Continuing Operations | -437.99 | -521.96 | -615.12 | 515.84 | 528.58 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.06 | - | - | Upgrade
|
| Net Income | -437.99 | -521.96 | -615.06 | 515.84 | 528.58 | Upgrade
|
| Net Income to Common | -437.99 | -521.96 | -615.06 | 515.84 | 528.58 | Upgrade
|
| Net Income Growth | - | - | - | -2.41% | - | Upgrade
|
| Shares Outstanding (Basic) | 139 | 136 | 134 | 133 | 130 | Upgrade
|
| Shares Outstanding (Diluted) | 139 | 136 | 134 | 135 | 133 | Upgrade
|
| Shares Change (YoY) | 1.67% | 1.58% | -0.50% | 1.03% | 11.98% | Upgrade
|
| EPS (Basic) | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 | Upgrade
|
| EPS (Diluted) | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 | Upgrade
|
| EPS Growth | - | - | - | -3.28% | - | Upgrade
|
| Free Cash Flow | -396.61 | -453.65 | -800.36 | 1,595 | -69.41 | Upgrade
|
| Free Cash Flow Per Share | -2.86 | -3.33 | -5.97 | 11.83 | -0.52 | Upgrade
|
| Gross Margin | - | - | - | 61.57% | 53.09% | Upgrade
|
| Operating Margin | -682.68% | -724.51% | -767.10% | 51.56% | 38.41% | Upgrade
|
| Profit Margin | -638.88% | -703.40% | -713.69% | 31.92% | 48.25% | Upgrade
|
| Free Cash Flow Margin | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% | Upgrade
|
| EBITDA | -456.34 | -523.06 | -641.64 | 839.85 | 426.56 | Upgrade
|
| EBITDA Margin | - | - | - | 51.98% | 38.94% | Upgrade
|
| D&A For EBITDA | 11.68 | 14.56 | 19.45 | 6.78 | 5.81 | Upgrade
|
| EBIT | -468.02 | -537.62 | -661.09 | 833.07 | 420.75 | Upgrade
|
| EBIT Margin | - | - | - | 51.56% | 38.41% | Upgrade
|
| Effective Tax Rate | - | - | - | 31.61% | 3.86% | Upgrade
|
| Revenue as Reported | 68.56 | 74.21 | 86.18 | 1,616 | 1,095 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.